We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$3.2M
Cap. Flow
-$7.27M
Cap. Flow %
-1.76%
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247

Top Buys

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$21.4M
2
STLA icon
Stellantis
STLA
+$18M
3
CNH
CNH Industrial
CNH
+$11.6M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.3M
5
IVE icon
iShares S&P 500 Value ETF
IVE
+$6.71M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$23.5M
2
LIN icon
Linde
LIN
+$8.45M
3
V icon
Visa
V
+$5.42M
4
ALC icon
Alcon
ALC
+$3.14M
5
TMUS icon
T-Mobile US
TMUS
+$3.04M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.6%
2 Technology 15.31%
3 Miscellaneous 15.03%
4 Industrials 9.82%
5 Financials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QSR icon
751
Restaurant Brands International
QSR
$26.4B
$604 ﹤0.01%
10
– –
FSM icon
752
Fortuna Silver Mines
FSM
$3.42B
$597 ﹤0.01%
153
– –
SAGE
753
DELISTED
Sage Therapeutics
SAGE
$596 ﹤0.01%
14
– –
PGRE
754
DELISTED
Paramount Group
PGRE
$592 ﹤0.01%
71
– –
EAF icon
755
GrafTech
EAF
$214M
$591 ﹤0.01%
5
– –
MASI
756
DELISTED
Masimo
MASI
$586 ﹤0.01%
2
– –
EPOL icon
757
iShares MSCI Poland ETF
EPOL
$819M
$569 ﹤0.01%
27
– –
PJP icon
758
Invesco Pharmaceuticals ETF
PJP
$547M
$568 ﹤0.01%
7
– –
AAT
759
American Assets Trust
AAT
$1.33B
$563 ﹤0.01%
15
– –
JMIA
760
Jumia Technologies
JMIA
$978M
$559 ﹤0.01%
49
-3,402
-99% -$53.1K
MYRG icon
761
MYR Group
MYRG
$4.31B
$553 ﹤0.01%
5
-2,381
-100% -$258K
NVEE
762
DELISTED
NV5 Global
NVEE
$552 ﹤0.01%
16
– –
BR icon
763
Broadridge
BR
$19.1B
$548 ﹤0.01%
3
– –
GRVY
764
GRAVITY
GRVY
$490M
$545 ﹤0.01%
8
– –
LEG
765
DELISTED
Leggett & Platt
LEG
$535 ﹤0.01%
13
– –
DDOG icon
766
Datadog
DDOG
$84.3B
$534 ﹤0.01%
3
-660
-100% -$112K
CHWY icon
767
Chewy
CHWY
$8.52B
$531 ﹤0.01%
9
-1,219
-99% -$79.7K
ELS icon
768
Equity Lifestyle Properties
ELS
$11.8B
$526 ﹤0.01%
6
-59
-91% -$4.96K
CYBR
769
DELISTED
CyberArk
CYBR
$520 ﹤0.01%
3
– –
EMTL
770
DELISTED
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
$488 ﹤0.01%
10
-3,196
-100% -$159K
NNN icon
771
NNN REIT
NNN
$8.04B
$481 ﹤0.01%
10
– –
EFA icon
772
iShares MSCI EAFE ETF
EFA
$78B
$472 ﹤0.01%
6
– –
RPD icon
773
Rapid7
RPD
$852M
$471 ﹤0.01%
4
-1,184
-100% -$146K
LCII icon
774
LCI Industries
LCII
$2.13B
$468 ﹤0.01%
3
– –
BXP icon
775
Boston Properties
BXP
$10.2B
$461 ﹤0.01%
4
– –
29 30
31
32 33

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q4 2021 Portfolio in Review

As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Exane Derivatives's Q4 2021 filing shows 83 new, 245 increased, 309 reduced and 247 closed positions. Its largest new stake was EngageSmart, Inc.: 45,605 shares worth $1.1M. The largest sale was UBS Group, an estimated $23.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Miscellaneous.

  • Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
  • Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
  • Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
  • Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
  • Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
  • Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
  • Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.